A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 105.22
GOOG 539.78
MSFT 46.13
BAC 16.72
FB 80.67

Recently Added

BBRY 10.26
CMRE 19.85
NCLH 35.02
EXPR 14.09
ANF 31.69

Gaining Speed

ANF 31.69
EXPR 14.09
NCLH 35.02
TRGP 127.34
TRP 48.40

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!